ROCKVILLE, MdThe Center for Prostate Disease Research (CPDR)
has opened a new freestanding research center to consolidate its
many initiatives and allow these programs to continue to develop and
expand. The new site is the nations only facility dedicated
solely to prostate disease research.
With approximately 20,000 square feet of space, the center houses
basic research and molecular biology laboratories as well as a
comprehensive prostate cancer patient database center; a prostate
research library; a tumor tissue, DNA, RNA, cell, and serum bank; and
an educational center for military health care providers.
The CPDR, established by Congress in 1991, is a Department of Defense
program conducted in collaboration with the Uniformed Services
University of the Health Sciences and the Henry M. Jackson Foundation
for the Advancement of Military Medicine.
The CPDR focuses on identifying genetic prognostic markers to help
physicians determine the best treatment for prostate disease and is
also developing new molecular treatment strategies.
In its 8-year history, researchers at the CPDR have achieved several
milestones in the battle against prostate disease. Among its many
breakthroughs, the CPDR counts the discovery of the role played by
several human genes in prostate cancer as well as the establishment
of a landmark clinical database that will contain information on
consenting prostate cancer patients treated within the military
health system. This database will allow researchers to utilize
previously unavailable clinical information to further their